PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
18-Dec-2023 GE HealthCare Management to Present at 42nd Annual J.P. Morgan Healthcare Conference Businesswire
18-Dec-2023 Lineage Announces Submission of OPC1 Investigational New Drug Amendment for Treatment of Chronic and Subacute Spinal Cord Injury Businesswire
18-Dec-2023 Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration Businesswire
18-Dec-2023 Eikon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference Businesswire
18-Dec-2023 Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines Businesswire
18-Dec-2023 Global Air Cargo Market Analysis and Forecasts to 2028 - Factors Driving Growth Include Just-in-Time Manufacturing, E-commerce and Temperature-Sensitive Shipments - ResearchAndMarkets.com Businesswire
18-Dec-2023 ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023 Businesswire
18-Dec-2023 Azura Ophthalmics Announces Positive Results from Phase 2 Clinical Trial of AZR-MD-001 in Patients with Contact Lens Discomfort Businesswire
18-Dec-2023 Can-Fite Received FDA Positive Response to Psoriasis Pediatric Plan Businesswire
18-Dec-2023 Verastem Oncology Selects Oral KRAS G12D Inhibitor GFH375/VS-7375 as Lead Program in Discovery and Development Collaboration with GenFleet Therapeutics Businesswire
18-Dec-2023 Viridian Therapeutics Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program with Extended Half-Life for Pivotal Development in Thyroid Eye Disease Businesswire
18-Dec-2023 European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy for New First-Line Indications in Advanced HER2-Negative Gastric or GEJ Adenocarcinoma in Tumors Expressing PD-L1 (CPS ≥1) and Advanced Biliary Tract Cancer Businesswire
18-Dec-2023 Biocytogen Enters into Antibody Agreement with Ona Therapeutics to Develop Antibody-Drug Conjugates Targeting Solid Tumors Businesswire
18-Dec-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
18-Dec-2023 Sensorion Provides an Update on NOTOXIS, its Proof of Concept Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) Businesswire
18-Dec-2023 Innate Pharma Announces Leadership Change Businesswire
18-Dec-2023 Eurofins Reinforces Its Agroscience Contract Research Services by Acquiring SGS’ Crop Science Operations Businesswire
16-Dec-2023 Takeda obtient l’avis favorable du CHMP pour HYQVIA® en tant que traitement d’entretien chez les patients atteints de polyneuropathie inflammatoire démyélinisante chronique (PDIC) Businesswire
16-Dec-2023 Takeda recibe la opinión positiva del CHMP para HYQVIA® como terapia de mantenimiento en pacientes con polineuropatía desmielinizante inflamatoria crónica (PDIC) Businesswire
16-Dec-2023 Takeda erhält positive CHMP-Stellungnahme für HYQVIA® als Erhaltungstherapie bei Patienten mit chronisch entzündlicher demyelinisierender Polyneuropathie (CIDP) Businesswire